::ilegx:: 2011 Meeting

Interdisciplinary Leg Initiative

3rd ilegx annual meeting
11-12 April 2011
an integral part of the
Charing Cross Symposium

3rd ilegx annual meeting

We learned in the first two ilegx annual meetings that the key to success was both early referral to a specialist centre and interdisciplinary team working to save legs

The 3rd ilegx annual meeting tackles the four major causes of amputation. It will be an integral part of the 33rd Charing Cross International Symposium, which attracts a multi-disciplinary audience of vascular specialists from around the world. In 2010, 2750 delegates attended from 75 countries.

ilegx in the UK

BIBA Medical has been awarded the opportunity to arrange various innovation showcases alongside the newspapers and this provides an unexpected opportunity to project the ilegx concept - just where it needs to be heard - in the heart of Government and health policy circles surrounded by very senior leaders of health technology companies. Therefore the ilegx programme directors will introduce the ilegx interdisciplinary leg initiative at the Healthcare Innovation Expo to be held on the 9-10 March 2011 in ExCel, London, UK. This event is supported by the Department of Health and the NHS and aims to be one of the top 5 global healthcare innovation events attracting 10,000 delegates.

Click here to register

3rd ilegx annual meeting
Preliminary programmeTackling Four of the Major Causes of Amputation

Monday 11 April 2011

introductionChairman: Roger Greenhalgh, Imperial College, London, United Kingdom

11.00-11.10
IntroductionRoger Greenhalgh, Imperial College, London, United Kingdom

11.10-11.30
ilegx PhilosophyMichael Edmonds, London, United Kingdom
Dieter Mayer, Zürich, Switzerland
Gunnar Tepe, Rosenheim, Germany
Giacomo Clerici, Sesto San Giovanni, Italy

ilegx-APWCA transatlantic sessionChairman: Roger Greenhalgh, Imperial College, London, United Kingdom 11.30-12.00
Transatlantic Effort To Reduce AmputationSteven Kravitz, Richboro, PA, United States

12.00-13.00
Necrosis, Apoptosis, Senescence enlightenedDariene McCord, Iowa City, IA, United States
13.00-13.15
Discussion

13.15-14.30
LUNCH/EXHIBITION

Infection & NeuropathyChairman: Michael Edmonds, London, United Kingdom

14.30-14.40
Measures to fight MRSA: From infection control to therapySteven PercivalWinsford, United Kingdom

14.40-14.50
Discussion

14.50-15.00
Best Choice AntibioticsChristian Ruef, Zurich, Switzerland

15.00-15.10
Discussion

15.10-15.30
Interactive Case Presentation 1 Michael Edmonds, London, United Kingdom

15.30-15.40
Compliance and Behaviour of DiabeticsLoretta Vileikyte, Manchester, United Kingdom

15.40-15.50
Discussion

15.50-16.00
Management of NeuropathyAndrew Boulton, Manchester, United Kingdom

16.00-16.10
Discussion

16.10-17.00
Interactive Case Presentation 2, 3 and 4Michael Edmonds, London, United Kingdom

17.00-18.00
INDUSTRY RECEPTION

Tuesday 12 April 2011

IschAemia I - Endovascular First

Chairman: Gunnar Tepe, Rosenheim, Germany

09.00-09.10
Extreme InterventionsLanfroi. Graziani, Brescia, Italy

09.10-09.20
Discussion

09.20-09.30
Subintimal angioplasty in DiabeticsAmman Bolia, Leicester, United Kingdom

09.30-09.40
Discussion

09.40-09.50
Early Endovascular Treatment Reason for Drop of Amputation Rate?Peter Huppert, Darmstadt, Germany

09.50-10.00
Discussion

IschAemia II - Vascular Surgery

Chairman: Dieter Mayer, Zürich, Switzerland

10.00-10.10
Distribution of Arterial DiseaseGunnar Tepe,Rosenheim, Germany

10.10-10.20
Discussion

10.20-10.30
Dispelling the Myths of Bypass Surgery in Diabetic LegsHisham Rashid, London, United Kingdom

10.30-10.40
Discussion

Ischemia III - Vascular Debate
Chairman: Giacomo Clerici, Sesto San Giovanni, Milan, Italy

10.40-11.30
ilex great debate including case presentation:
Dedicated below the knee endovascular intervention is the gold standard rather than distal bypass

For the motion: Gunnar Tepe, Rosenheim, Germany
Against the motion: Michael Edmonds, London, United KingdomDieter Mayer, Zürich, Switzerland

11.30-12.30
LUNCH/EXHIBITION

Charcot Foot Chairman: Michael Edmonds, London, United Kingdom

12.30-12.40
Early Diagnosis of Charcot DiseaseGiacomo Clerici, Sesto San Giovanni, Milian, Italy

12.40-12.50
Discussion

12.50-13.00
Mechanisms of Charcot Disease Nina Petrova, London, United Kingdom

13.00-13.10
Discussion

13.10-13.20
Management of Charcot Disease Thomas Böni, Zurich, Switzerland

13.20-13.30
Discussion

13.30-14.00
Interactive Case Presentations 6 and 7 Michael Edmonds, London, United Kingdom

Meeting SummaryChairman: Roger Greenhalgh, Imperial College, London, United Kingdom

14.00-14.10
Neuropathy and Charcot Michael Edmonds, London, United Kingdom

14.10-14.20
Endovascular First Gunnar Tepe, Rosenheim, Germany

14.20-14.30
Vascular Surgery
Dieter Mayer, Zürich, Switzerland

Click here to register